Mechanism- and Immune Landscape-Based Ranking of Therapeutic Responsiveness of 22 Major Human Cancers to Next Generation Anti-CTLA-4 Antibodies is a research paper published in Cancers (2020). On theSindex it has a DataRank of 0. It has been cited 14 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: AI64350
National Institutes of Health
Grant: CA227671
Melanoma Research Alliances
Grant: MRATSA 559400
OncoImmune, Inc
Grant: N/A
National Key Research and Development Program of China
Grant: 2016YFA0500304
Sci-Tech Project Foundation of Guangzhou City
Grant: 201607020038
National Nature Science Foundation in China (NSFC)
Grant: 81773052
National Nature Science Foundation in China (NSFC)
Grant: 81572806
Science and technology projects of Guangdong. Province
Grant: 2016A020215086
Guangdong Innovative and Entrepreneurial Research Team Program
Grant: 2016ZT06S638
National Institutes of Health
Grant: 5R01CA227671-02
A Mouse Model to Assess Long Term Immunotherapy-related Adverse Effects in Children
National Institutes of Health
Grant: 5R01AI064350-05
Checkpoints of Host Response to Cellular Injuries
FWCI
0.84
Citation Percentile
0.7%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals